Colorado Clinical and Translational Sciences Institute (CCTSI)

Colorado Clinical and Translational Sciences Institute (CCTSI)

@cctsi.bsky.social

At the Colorado Clinical and Translational Sciences Institute (CCTSI) we help build research teams teams of the future, speed the development of new treatments and improve human health. https://cctsi.cuanschutz.edu

452 followers406 following576 posts

A CCTSI pilot grant helped Achim Klug, PhD, gather data and secure #NIH funding to advance a potential new treatment for central auditory processing disorder into human trials. And he started a company to boot! The treatment is being tested in a Phase #clinical trial. @cuanschutz-dpb.bsky.social

buff.lyThe Elements of InnovationAchim Klug, PhD, received a pilot grant from the Colorado Clinical and Translational Sciences Institute (CCTSI), which was instrumental to his science. Now he is testing a novel method to solve…

Last week, our Director of Community Engagement, @famdocdon.bsky.social, presented the Ascona Prize at the 24th International Balint Congress in Denmark. The prize honors medical students' essays about meaningful patient relationships. This year's winners came from Brazil, Australia and Hungary.

buff.lyDonald Nease, MD, Presents Ascona Prize to Medical Students at the 24th International Balint CongressHighlight of DFM Faculty, Donald Nease, MD, who presented the Ascona Prize to three medical students at the 24th International Balint Congress.

Hear from the 2026 Chancellor’s Distinguished Research Lectureship Award recipient Wendy M Kohrt, PhD, as she shares insights from her more than 30 years of research on exercise and bone health. 🗓️ Oct. 14 📍 Hensel Phelps West Auditorium, RC1N @cumedicalschool.bsky.social

buff.lySummary - Fall 2026 Chancellor's Distinguished Research LectureJoin CU Anschutz for the Fall 2026 Chancellor’s Distinguished Research Lecture:

Shoutout to our fellow CTSA hub for research showing how occupational therapy could improve outcomes and reduce health care costs for patients with diabetes!

CCOS (CTSA Program)@ccos-ctsa.bsky.social

Could occupational therapy improve outcomes and reduce costs for patients with diabetes? A randomized study funded by a Southern California Clinical and Translational Science Institute pilot award found Lifestyle Redesign® generated more than $250K in savings. #CTSAProgram https://ow.ly/EAKF50ZOoQk

Join us on Oct. 14 for the Fall 2026 Chancellor’s Distinguished Research Lecture featuring Wendy Kohrt, PhD: “30+ Years of Exercise and Bone Research – And a Shift from Benefits to Risks.” 📍 Hensel Phelps West Auditorium, RC1N 📝 buff.ly/JSbovKX @cumedicalschool.bsky.social

web.cvent.comSummary - Fall 2026 Chancellor's Distinguished Research LectureJoin CU Anschutz for the Fall 2026 Chancellor’s Distinguished Research Lecture:

Can oral #semaglutide reduce #alcohol use? A study conducted at our Clinical Translational Research Center (CTRC) found that the popular diabetes and weight loss drug reduced heavy drinking and alcohol-related harm in adults with Alcohol Use Disorder. #AUD @cumedicalschool.bsky.social

axios.comStudy: GLP-1 drugs may curb alcohol cravings, tooPeople who took oral semaglutide — the main ingredient in Ozempic — had significantly fewer heavy-drinking days, consumed less when they did drink and reported weaker alcohol cravings.

Our Director of Translational Informatics, Jayashree Kalpathy-Cramer, PhD, is leading @cuanschutz.bsky.social’s work on HEREDITARY, a global project improving the detection and treatment of neurodegenerative and gut microbiome-related conditions. Her work could help detect Parkinson’s earlier.

buff.lyInternational Research Asks: Can AI Detect Parkinson’s Disease from Eye Scans?CU Anschutz is the only U.S. partner involved in HEREDITARY, an international research project that analyzes the use of AI and gut-brain interactions.

Shoutout to our Director of Translational Informatics, Jayashree Kalpathy-Cramer, PhD! She’s leading @cuanschutz.bsky.social's efforts in the HEREDITARY project to improve the detection and treatment of neurodegenerative and gut microbiome-related conditions.

Could the eyes hold clues about brain health? 👁️ CU Anschutz researchers Jayashree Kalpathy-Cramer, PhD, and Giacomo Nebbia, PhD, are using AI and retinal images to study biomarkers linked to Parkinson’s disease and multiple sclerosis. 🔬 Read more: https://bit.ly/3T8SGXs

Colorado Clinical and Translational Sciences Institute (CCTSI) reposted

📢 We're excited to announce the 2026-2027 Pragmatic Electronic Health Record (EHR)-Embedded Trials (PEET) Request for Applications (RFA)! One two-year award will #fund a pilot #pragmatic clinical trial within UCHealth using Epic EHR features. Learn more & apply: 🔗https://buff.ly/Uww5aOe

cctsi.cuanschutz.eduPragmatic Research Resources | CCTSIPragmatic research spans a wide variety of research activities, and research can be more or less pragmatic in different ways

👏 Congratulations to our CCTSI leaders and researchers named to 5280 Magazine’s 2026 Top Doctors list! We’re proud to see their contributions to patient care, research and leadership recognized among Colorado’s best.

news.cuanschutz.edu5280 Magazine Top Doctors for 2026Denver's 5280 Magazine has released its 2026 list of Top Doctors, and CU Anschutz School of Medicine faculty continue to be recognized among Colorado's leading physicians.

Former CCTSI leader Wendy Kohrt, PhD, is raising awareness about a potential hidden risk of GLP-1 #weight-loss medications for postmenopausal women: bone loss. Learn why #menopause and rapid weight loss may create a "perfect storm" for bone health. 👇

uchealth.orgA ‘perfect storm’ for bone loss in women: Menopause and GLP-1 weight-loss drugsWomen in menopause are turning to GLP‑1 weight-loss drugs. One expert warns they may speed bone loss. Here’s what to know.

Spend less time on repetitive research tasks and more time advancing your science. Join CCTSI's new Hands-On AI for Research workshop series led by Jayashree Kalpathy-Cramer, PhD, to learn how to use #AI to streamline research tasks. Open to CU Anschutz faculty and trainees. @cueyecenter.bsky.social

buff.lyAI for ResearchArtificial intelligence tools are rapidly becoming part of the day-to-day research workflow, yet many of us lack practical guidance on how to use them effectively and responsibly. This hands-on…

Colorado Clinical and Translational Sciences Institute (CCTSI) reposted

In an age where patients turn to chatbots and artificial intelligence for answers to their medical questions, effective human-to-human communication remains essential, says Caroline Tietbohl, PhD, MA. Read More: tinyurl.com/55zrccdm #HealthServicesResearch #ACCORDSInnovation #FamilyMedicine

news.cuanschutz.eduNew Research Investigates How Physicians Can Best Reassure PatientsIn an age where patients turn to chatbots and artificial intelligence for answers to medical questions, effective human-to-human communication remains essential, says Caroline Tietbohl, PhD, MA.

Colorado Clinical and Translational Sciences Institute (CCTSI) reposted

Can oral semaglutide reduce alcohol use? A study from the CU Anschutz School of Medicine found that the popular diabetes and weight loss drug reduced heavy drinking and alcohol-related harm in adults with Alcohol Use Disorder. Learn more about the clinical trial: https://bit.ly/4xw2Ks0

news.cuanschutz.eduCan Oral Semaglutide Reduce Alcohol Use? CU Anschutz Clinical Trial Shows Fewer Heavy Drinking DaysCan Oral Semaglutide Reduce Alcohol Use? CU Anschutz Clinical Trial Shows Fewer Heavy Drinking Days

Colorado Clinical and Translational Sciences Institute (CCTSI) reposted

UC Davis CTSC’s Impact Story, “Protecting Federal Research Funding Through ClinicalTrials.gov Support,” is now live on the CCOS website 🎉 The story highlights how CTSC support strengthens compliance and protects research continuity. To read more, please visit: ccos-cc.ctsa.io/impact/stori...

ccos-cc.ctsa.ioProtecting Federal Research Funding Through ClinicalTrials.gov Support<p>ClinicalTrials.gov support resolved RPPR discrepancies, protected NIH funding, and strengthened regulatory reporting workflows.</p>